These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 19938136)

  • 1. Posttransplant metabolic syndrome: an epidemic waiting to happen.
    Pagadala M; Dasarathy S; Eghtesad B; McCullough AJ
    Liver Transpl; 2009 Dec; 15(12):1662-70. PubMed ID: 19938136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events.
    Laish I; Braun M; Mor E; Sulkes J; Harif Y; Ben Ari Z
    Liver Transpl; 2011 Jan; 17(1):15-22. PubMed ID: 21254340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of development of the metabolic syndrome after orthotopic liver transplantation.
    Ruiz-Rebollo ML; Sánchez-Antolín G; García-Pajares F; Fernández-Orcajo P; González-Sagrado M; Cítores-Pascual MA; Velicia-Llames R; Caro-Patón A
    Transplant Proc; 2010 Mar; 42(2):663-5. PubMed ID: 20304218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cumulative risk of cardiovascular events after orthotopic liver transplantation.
    Albeldawi M; Aggarwal A; Madhwal S; Cywinski J; Lopez R; Eghtesad B; Zein NN
    Liver Transpl; 2012 Mar; 18(3):370-5. PubMed ID: 22140067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity, hyperlipidemia, and metabolic syndrome.
    Charlton M
    Liver Transpl; 2009 Nov; 15 Suppl 2():S83-9. PubMed ID: 19877024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular risk, atherosclerosis and metabolic syndrome after liver transplantation: a mini review.
    Oliveira CP; Stefano JT; Alvares-da-Silva MR
    Expert Rev Gastroenterol Hepatol; 2013 May; 7(4):361-4. PubMed ID: 23639094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome in liver transplant recipients: prevalence and association with major vascular events.
    Laryea M; Watt KD; Molinari M; Walsh MJ; McAlister VC; Marotta PJ; Nashan B; Peltekian KM
    Liver Transpl; 2007 Aug; 13(8):1109-14. PubMed ID: 17663411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo nonalcoholic fatty liver disease after liver transplantation.
    Seo S; Maganti K; Khehra M; Ramsamooj R; Tsodikov A; Bowlus C; McVicar J; Zern M; Torok N
    Liver Transpl; 2007 Jun; 13(6):844-7. PubMed ID: 17029282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome and liver transplantation.
    Hanouneh IA; Zein NN
    Minerva Gastroenterol Dietol; 2010 Sep; 56(3):297-304. PubMed ID: 21037547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of pre-disease risk factors within metabolic syndrome on all-cause and cardiovascular disease mortality.
    Tsai SP; Wen CP; Chan HT; Chiang PH; Tsai MK; Cheng TY
    Diabetes Res Clin Pract; 2008 Oct; 82(1):148-56. PubMed ID: 18757109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular risk factors in long-term follow-up after orthotopic liver transplantation.
    Guckelberger O; Bechstein WO; Neuhaus R; Luesebrink R; Lemmens HP; Kratschmer B; Jonas S; Neuhaus PL
    Clin Transplant; 1997 Feb; 11(1):60-5. PubMed ID: 9067697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular risk profile of patients with acute liver failure after liver transplantation when compared with the general population.
    Aberg F; Jula A; Höckerstedt K; Isoniemi H
    Transplantation; 2010 Jan; 89(1):61-8. PubMed ID: 20061920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
    Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of nonalcoholic fatty liver disease and the metabolic syndrome on progression of fibrosis in patients with recurrent HCV after liver transplantation.
    Mindikoglu AL; Regev A; Casanova-Romero PY; Bejarano PA; Martinez EJ; Tzakis AG; Schiff ER
    Transplant Proc; 2006 Jun; 38(5):1440-4. PubMed ID: 16797327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-liver transplant obesity and diabetes.
    T D Correia MI; Rego LO; Lima AS
    Curr Opin Clin Nutr Metab Care; 2003 Jul; 6(4):457-60. PubMed ID: 12806221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome and liver transplantation: a review and guide to management.
    Watt KD; Charlton MR
    J Hepatol; 2010 Jul; 53(1):199-206. PubMed ID: 20451282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular risk factors following orthotopic liver transplantation: predisposing factors, incidence and management.
    Desai S; Hong JC; Saab S
    Liver Int; 2010 Aug; 30(7):948-57. PubMed ID: 20500807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence evolution and impact of cardiovascular risk factors on allograft and renal transplant patient survival.
    Díaz JM; Gich I; Bonfill X; Solà R; Guirado L; Facundo C; Sainz Z; Puig T; Silva I; Ballarín J
    Transplant Proc; 2009; 41(6):2151-5. PubMed ID: 19715859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardiovascular risk factors and prevention in women: similarities and differences].
    Sclavo M
    Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome in liver transplantation: relation to etiology and immunosuppression.
    Bianchi G; Marchesini G; Marzocchi R; Pinna AD; Zoli M
    Liver Transpl; 2008 Nov; 14(11):1648-54. PubMed ID: 18975273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.